Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Can-Fite BioPharma Ltd. sell Lokrim

Start price
€11.60
14.11.21 / 20%
Target price
-
14.11.22
Performance (%)
-33.62%
End price
€7.70
15.11.22
Summary
This prediction ended on 15.11.22 with a price of €7.70. The SELL prediction by Lokrim for Can-Fite BioPharma Ltd. performed very well with a performance of -33.62%. Lokrim has 20% into this prediction This prediction was marked as speculative and is excluded from Lokrim's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Can-Fite BioPharma Ltd. - - -
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

According to Lokrim what are the pros and cons of Can-Fite BioPharma Ltd. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment

Comments by Lokrim for this prediction

In the thread Can-fite Biopharma Ltd. diskutieren
Prediction Sell
Perf. (%) -33.62%
Target price
Change
Ends at 14.11.22

Sell Can-fite Biopharma Ltd.

In the thread Trading Can-fite Biopharma Ltd.
Prediction Buy
Perf. (%) -33.62%
Target price
Change
Ends at 14.11.22

Die von Lokrim gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Lokrim for Can-Fite BioPharma Ltd.

buy
Can-Fite BioPharma Ltd.

Start price
Target price
Perf. (%)
€21.80
22.02.21
-
22.02.22
-46.79%
14.11.21

Probably not worthwhile Investment